ISSAR Pharma

Home       Therapeutic Areas      Bone and Joints

We at ISSAR, are translating decades of research, innovation and development into perspective therapeutics for the second leading cause of death worldwide: CANCER

Aiming to reach the undruggable targets with the modification of naturally occurring substances (peptides) to transform the prospect of treatment for the most dreadful disease.


Oncology is the branch of medicine that deals with research, identification, and treatment of cancer.

Cancer occurs due to abnormal, rapid and uncontrollable growth of cells invading different parts of the body. Cancer accounts for the second leading cause of deaths worldwide after cardiovascular disease. The number of deaths due to cancer is predicted to exceed 13 million by the year 2030.

As a result of technological advancement in early detection and treatment of the condition, the survival rate for most common cancers has risen up from 43% to 64% in men and 57%-64% in women.

Our Work In Oncology

Cervical cancer cells, 3D illustration. Malignant tumor of cervix uteri

Our Focused Therapies